Tumor pathologies of the prostate gland are represented by benign prostate tumor and prostate cancer and are generally seen after 50 years. The objective of this work was to study the epidemiological, clinical, paraclinical and therapeutic aspects of prostate tumors at the General Reference Hospital of Panzi (DRC). Patients and Methods: Retrospective cross-sectional study on 70 patients followed in hospital or on an outpatient basis for prostate tumor in the urology department of the General Reference Hospital of Panzi from January 1, 2013 to December 31, 2017. The epidemiological, clinical and paraclinical parameters (pathology with Gleason score, prostate volume on ultrasound, urinary impact on ultrasound, urea level, creatinine level and PSA level) and therapeutics were studied. Results: Prostate tumors represent 3.84% of surgical pathologies. The average age of the patients was 68.2 years with the extremes of 47 and 90 years old. The patients were transferred in 78.6% of the cases. Acute urine retention was the most common reason for consultation with 42.8%. The PSA rate > 4 ηg in 92.9% of the cases. Benign prostatic hyperplasia was found in 62.8% of patients against 35.7% of prostate adenocarcinoma and 41.7% of prostate cancers were moderately differentiated. The prostate volume was 41 - 60 g in 35.7% of the cases. No urinary impact in 71.4% of patients. Surgical treatment was in 85.7% and RTUP was the most used at 40%. A hospital stay between 15 and 21 days in 30% of cases. The cure rate was 81.4% and 14.3% developed urethral stenosis. Conclusion: Prostate tumors are common in people over the age of 50 who see for acute retention of urine. Benign enlarged prostate is the most common. Treatment is codified and in the event of a complicated prostatic tumor, surgery remains the choice for the comfort of the patients and the popularization of an early detection of these pathologies is necessary for the prevention of complications.
References
[1]
Munyantwari, A. and Swedi, M. (2017) Prevalence of Voiding Disorders in Subjects Aged 50 Years or Older in Goma. Revue Médicale des Grands Lacs, 8, 4-7.
[2]
Seisen, T. and Evanguelos, X. (2014/2015) Benign Prostatic Hyperplasia, Item 123/127. https://www.urofrance.org/
[3]
Aruna, V. and John, T. (2012) Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms. The New England Journal of Medicine, 367, 248-257. https://doi.org/10.1056/NEJMcp1106637
[4]
Debbagh, A., Dahami, Z., Fekak, H., Joual, A., Bennani, S., Elmrini, M., et al. (2002) Anatomical and Radiological Correlations in Benign Prostatic Hyperplasia. Annales d’Urologie, 36, 190-195. https://doi.org/10.1016/S0003-4401(02)00098-0
[5]
Hoepffner, J., Fontaine, E. and Enfadel, S. (1994) Cervicoprostatic Groove Technique in Adenomas of the Young Subject Wishing to Preserve Ejaculations. Progrès en Urologie, 4, 371-377.
[6]
Eric, C. (2006) Urology. 5th Edition, Collection Med Line ENC, Paris.
[7]
ESMO (2014) What Is Prostate Cancer? Let Us Explain. https://www.esmo.org/
[8]
Ngandu, T. (2018) Prostate Cancer in a Company in Mbuji-Mayi: Epidemiological, Biological and Histopathological Aspects. Revue Médicale des Grands Lacs, 9, 9-14.
[9]
Chatelain, C., Denis, L., Debruine, F. and Murphy, G. (1991) Benign Prostatic Hyperplasia in Questions: An Update. Comité Scientifique S-Khoury, Paris.
[10]
Daubisse, L., Lang, S., Lunardi, P., Tollon, C., Thoulouzan, M., Latorzeff, E., et al. (2017) Prostate Cancer, Quality of Management in Midi-Pyrénées in 2011. Progrès en Urologie, 27, 69-79.
[11]
Benatta, M., Mehdid, M., Benhatchi, N., Djazouli, M.A. and Boualga, K. (2012) Results of Prostatic Biopsies in Algerian Patients with an Elevated PSA and/or Suspicious Digital Rectal Examination. African Journal of Urology, 18, 138-142. https://doi.org/10.1016/j.afju.2012.08.008
[12]
Tengue, K., Kpatcha, T., Botcho, G., Leloua, E., Amavi, A., Sikpa, K., et al. (2016) Epidemiological, Diagnostic, Therapeutic and Evolutionary Aspects of Prostate Cancer in Togo. African Journal of Urology, 22, 76-82. https://doi.org/10.1016/j.afju.2015.06.006
[13]
Mubenga, L.M., Burume, A., Chimanuka, D.M., Muhindo, L. and De Groote, P. (2018) Transurethral Resection: First Experience in Bukavu, DR Congo. Annales Africaines de Médecine, 11, 2890-2899.
[14]
Motte, T. (1990) Adenoma of the Prostate. Collection Impact-Internet Urologie, Paris, 103-118.
[15]
Botcho, G., Kpatcha, T., Tengue, K., Dossouvi, T., Sewa, E., Simlawo, K., et al. (2018) Morbidity and Mortality after Open Prostatectomy for Benign Prostatic Hyperplasia by Transvesical Approach at the Teaching Hospital of Kara, Togo. African Journal of Urology, 24, 353-358. https://doi.org/10.1016/j.afju.2018.01.008
[16]
Rouvière, H. and Delmas, A. (1992) Human Anatomy, Descriptive, Topographic and Functional. Tome II, Masson, Paris.
[17]
Rachida, S., Harir, N., Soumia, Z. and Feriel, S. (2014) Urological Cancers in Algeria: Histo-Epidemiological Profile about 348 Cases. African Journal of Cancer, 7, 126-131.
[18]
Troh, E., N’Dah, K.J., Doukoure, B., Kouamé, B., et al. (2014) Prostate Cancer in Ivory Coast: Epidemiological, Clinical and Pathological Aspects. African Journal of Cancer, 6, 202-2018. https://doi.org/10.1007/s12558-014-0314-5
[19]
Mugisho, B. (2018) Characteristics of Patients and Histopathological Profile of Parts from Prostate Adenomectomy in Kinshasa. In Annales Africaines de Médecine. https://www.facmed-unikin.net/
[20]
Luhiriri, N., Alumeti, D.M., Cirimwami, P. and Ahuka, O.L. (2016) Diagnostic and Surgical Management of Benign Prostatic Hypertrophy at Panzi Hospital/DRC. Uro’Andro, 1, 1-6.
[21]
Darré, T., Amégbor, K., Kpatcha, M., Tengue, K., Doh, K., Tchaou, M., et al. (2014) Urologic Cancers in Togo: Histo-Epidemiological Profile of 678 Cases. African Journal of Cancer, 6, 27-31. https://doi.org/10.1007/s12558-013-0296-3
[22]
Hounasso, P., Avakoudjo, J., Aouagbe, H., Tandje, Y., Ouake, A. and Alabi, M., et al. (2015) Diagnostic Aspects of Prostate Cancer in the Urology Department of CNHU-HKM Cotonou. Uro’Andro, 1, 10-16.
[23]
Dehayni, Y., Habibi, H., Balla, B., El Abiad, Y., Ammani, A., Qarro, A., et al. (2016) Capacity of Prostate Biopsy to Predict the Real Score of Prostate Cancer? African Journal of Urology, 22, 259-263. https://doi.org/10.1016/j.afju.2016.02.002
[24]
Verde, K.L. (2019) Traitement de 1ère intention du cancer de prostate localisé par Ultrasons Focalisés de Haute Intensité: Efficacité et tolerance. Aix-Marseille Université, Aix-en-Provence. https://dumas.ccsd.cnrs.fr/dumas-02047743
